The collective findings from immune cell profiling, genetic variations, and pathway analyses highlight KCa3.1 as a key modulator of immune responses in PAAD, reinforcing its association with an immunosuppressive tumor microenvironment. Here, KCNN4 is linked to pancreatic adenocarcinoma.